Fig. 5From: Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous populationGastric cancer PDXs respond robustly to lenvatinib. A Growth curves for the vehicle and lenvatinib-treated PDX lines. B Percent change in tumor volume of the vehicle and lenvatinib-treated PDX lines. Each dot represents one mouse. The error bar represents the standard error of the mean. C Vehicle and lenvatinib-treated tumors from PDX Line 1. D Percent change of mouse body weight throughout treatmentBack to article page